Patents 7show all

  • 5
    C12N - Microorganisms or enzymes
  • 2
    A61K - Preparations for medical, dental, or toilet purposes

Clinical Trials 2show all

1Phase 11Phase 2

SEC Filings show all


48
8-K

10
10-Q

3
10-K

1
D

1
S-1

Contact Information

SEC Form D Funding Events

DateOfferedSoldType
2012-03-22$3,804,991$3,804,991Equity, Option to Acquire, Security to be Acquired

Key Executives

  • Michael Cohen
    Executive Officer, Director
  • Roger Fidler
    Director
  • Steven Byle
    Executive Officer, Director
  • Ian McNiece
    Executive Officer, Director